Alaska Permanent Fund Corp Amgen Inc Transaction History

Alaska Permanent Fund Corp

$6.78 Billion
Q3 2024

A detailed history of Alaska Permanent Fund Corp transactions in Amgen Inc stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 53,770 shares of AMGN stock, worth $14.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

53,770

Previous 53,770 -0.0%

Holding current value

$14.3 Million

Previous $16.8 Million 3.13%

% of portfolio

0.26%

Previous 0.26%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $366,010 - $444,798	-1,393 Reduced 2.53%	53,770 $16.8 Million
Q1 2024 Apr 09, 2024	SELL	$268.87 - $324.56 $238,756 - $288,209	-888 Reduced 1.58%	55,163 $15.7 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $1.07 Million - $1.21 Million	-4,196 Reduced 6.96%	56,051 $16.1 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $260,849 - $323,851	-1,193 Reduced 1.94%	60,247 $16.2 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $5.37 Million - $6.34 Million	25,040 Added 68.79%	61,440 $13.6 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $278,042 - $353,286	-1,214 Reduced 3.23%	36,400 $9.56 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $1.77 Million - $2 Million	7,884 Added 26.52%	37,614 $8.48 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $6.53 Million - $7.26 Million	28,296 Added 1973.22%	29,730 $7.23 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $438 - $485	-2 Reduced 0.14%	1,434 $347,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $285,591 - $326,833	1,436 New	1,436 $326,000

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $143B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.

Account

Alaska Permanent Fund Corp Amgen Inc Transaction History